The latest press release from Taysha announces that they have got the go-ahead to include adolescents age 12 years and over in their trial. The third patient to be dosed is expected to be in the last quarter of 2023 or the first quarter of 2024. Read the full press release below.
Taysha-Gene-Therapies-Announces-Expanded-Eligibility-in-REVEAL-Phase-1_2-Adult-Trial-to-Include-Adolescent-Rett-Syndrome-Patients-1Download
Taysha expand age group in gene therapy trial in Canada to 12+ years.